https://www.selleckchem.com/pr....oducts/gc7-sulfate.h
Proliferation rate assessed by Ki67 was at least 90% in 18 of 20 cases. Eighteen patients received chemotherapy including etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (n = 13) and cyclophosphamide, doxorubicin, vincristine, and prednisone (n = 2). With a median follow-up time of 19 months, nine out of 17 patients died. Bone marrow involvement was associated with a poorer overall survival (median 4.7 months, P = 0.015). PBL is the second most common type of aggressive lymphoma and often presents in lymph node
Like
Comment
Share
